How Serious is Blood Clot Risk for Johnson & Johnson Vaccine

Updated April 13, 2021

Thomas A. Russo, MD, professor of medicine and chief of the Division of Infectious Diseases, was quoted by news outlets of rare blood clotting reported in six U.S. women after receiving Johnson & Johnson’s COVID-19 vaccine. The CDC and FDA recommended Tuesday that distribution of the J&J vaccine stop. Russo says that the news shouldn’t keep people from getting vaccinated against COVID-19. “There are two other very good vaccines in the mix,” he said.